東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Secondary hypertension

Morganti, Alberto.

FindBook

Google Book

Amazon

博客來

Secondary hypertension

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Secondary hypertension/ edited by Alberto Morganti, Enrico Agabiti Rosei, Franco Mantero.
其他作者:	Morganti, Alberto.
出版者:	Cham :Springer International Publishing : : 2020.,
面頁冊數:	x, 209 p. :ill., digital ;24 cm.
內容註:	1. Renal parenchimal disease -- 2. Atherosclerotic renovascular disease -- 3. Fibromuscular Dysplasia -- 4. Primary aldosteronism -- 5. Familial aldosteronism -- 6. Monogenic forms of hypertension. - 7. Pheochromocytoma - Paraganglioma -- 8. Cushing disease -- 9. Vascular disease -- 10. OSAS -- 11. Drug induced hypertension -- 12. Acromegaly -- 13. Organ damage in secondary hypertension. - 14. Hemodynamics and CV risk in secondary hypertension.
Contained By:	Springer Nature eBook
標題:	Hypertension. -
電子資源:	https://doi.org/10.1007/978-3-030-45562-0
ISBN:	9783030455620

Secondary hypertension
Secondary hypertension[electronic resource] /edited by Alberto Morganti, Enrico Agabiti Rosei, Franco Mantero. - Cham :Springer International Publishing :2020. - x, 209 p. :ill., digital ;24 cm. - Updates in hypertension and cardiovascular protection,2366-4606. - Updates in hypertension and cardiovascular protection..

1. Renal parenchimal disease -- 2. Atherosclerotic renovascular disease -- 3. Fibromuscular Dysplasia -- 4. Primary aldosteronism -- 5. Familial aldosteronism -- 6. Monogenic forms of hypertension. - 7. Pheochromocytoma - Paraganglioma -- 8. Cushing disease -- 9. Vascular disease -- 10. OSAS -- 11. Drug induced hypertension -- 12. Acromegaly -- 13. Organ damage in secondary hypertension. - 14. Hemodynamics and CV risk in secondary hypertension.

This book offers an overview of the latest advances in the epidemiological, pathophysiological, diagnostic and therapeutic aspects of secondary hypertension, provided by a group of the most highly respected European experts in this field. It is common belief that secondary forms of hypertension are rare, although in 95% of patients the cause of high blood pressure is unknown - euphemistically referred to as "essential". There is increasing evidence from epidemiological studies that the prevalence of secondary hypertension is much higher than previously thought, accounting for 20%-25% of all hypertensive patients. There are additional, very good reasons for identifying those patients with secondary hypertension: firstly, they are exposed to a greater risk of suffering major cardiovascular events than patients with essential hypertension who have the same blood pressure level, and for this reason require particular care. Secondly, these patients can be relieved of a lifetime of pharmacological therapy or, at least, have a chance to be treated with more specific and effective medications. A high degree of clinical skill is required to recognize the often vague and subtle symptoms and signs that characterize patients with secondary hypertension, and clinicians need to fully comprehend the mechanisms responsible for the development and maintenance of high blood pressure. Shedding new light on a complex area of cardiovascular medicine, the book enables readers to better treat affected patients.

ISBN: 9783030455620

Standard No.: 10.1007/978-3-030-45562-0doiSubjects--Topical Terms:

825110
Hypertension.

LC Class. No.: RC685.H8 / S436 2020

Dewey Class. No.: 616.132

Secondary hypertension
LDR:03023nmm a2200337 a 4500 001 2222702
003 DE-He213
005 20201124154938.0
006 m d
007 cr nn 008maaau
008 210108s2020 sz s 0 eng d
020 $a 9783030455620 $q (electronic bk.)
020 $a 9783030455613 $q (paper)
024 7 $a 10.1007/978-3-030-45562-0 $2 doi
035 $a 978-3-030-45562-0
040 $a GP $c GP
041 0 $a eng
050 4 $a RC685.H8 $b S436 2020
072 7 $a MJD $2 bicssc
072 7 $a MED010000 $2 bisacsh
072 7 $a MJD $2 thema
082 0 4 $a 616.132 $2 23
090 $a RC685.H8 $b S445 2020
245 0 0 $a Secondary hypertension $h [electronic resource] / $c edited by Alberto Morganti, Enrico Agabiti Rosei, Franco Mantero.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2020.
300 $a x, 209 p. : $b ill., digital ; $c 24 cm.
490 1 $a Updates in hypertension and cardiovascular protection, $x 2366-4606
505 0 $a 1. Renal parenchimal disease -- 2. Atherosclerotic renovascular disease -- 3. Fibromuscular Dysplasia -- 4. Primary aldosteronism -- 5. Familial aldosteronism -- 6. Monogenic forms of hypertension. - 7. Pheochromocytoma - Paraganglioma -- 8. Cushing disease -- 9. Vascular disease -- 10. OSAS -- 11. Drug induced hypertension -- 12. Acromegaly -- 13. Organ damage in secondary hypertension. - 14. Hemodynamics and CV risk in secondary hypertension.
520 $a This book offers an overview of the latest advances in the epidemiological, pathophysiological, diagnostic and therapeutic aspects of secondary hypertension, provided by a group of the most highly respected European experts in this field. It is common belief that secondary forms of hypertension are rare, although in 95% of patients the cause of high blood pressure is unknown - euphemistically referred to as "essential". There is increasing evidence from epidemiological studies that the prevalence of secondary hypertension is much higher than previously thought, accounting for 20%-25% of all hypertensive patients. There are additional, very good reasons for identifying those patients with secondary hypertension: firstly, they are exposed to a greater risk of suffering major cardiovascular events than patients with essential hypertension who have the same blood pressure level, and for this reason require particular care. Secondly, these patients can be relieved of a lifetime of pharmacological therapy or, at least, have a chance to be treated with more specific and effective medications. A high degree of clinical skill is required to recognize the often vague and subtle symptoms and signs that characterize patients with secondary hypertension, and clinicians need to fully comprehend the mechanisms responsible for the development and maintenance of high blood pressure. Shedding new light on a complex area of cardiovascular medicine, the book enables readers to better treat affected patients.
650 0 $a Hypertension. $3 825110
650 1 4 $a Cardiology. $3 861477
650 2 4 $a Nephrology. $3 894870
650 2 4 $a Endocrinology. $3 610914
650 2 4 $a Neurology. $3 588698
700 1 $a Morganti, Alberto. $3 3461681
700 1 $a Agabiti Rosei, Enrico. $3 3461682
700 1 $a Mantero, Franco. $3 3461683
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer Nature eBook
830 0 $a Updates in hypertension and cardiovascular protection. $3 2200366
856 4 0 $u https://doi.org/10.1007/978-3-030-45562-0
950 $a Medicine (SpringerNature-11650)